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Most eukaryotic pre-mRNAs contain non-coding sequences (introns) that must be removed in order to accu-
rately place the coding sequences (exons) in the correct reading frame. This critical regulatory pre-mRNA
splicing event is fundamental in development and cancer. It occurs within a mega-Dalton multicomponent
machine composed of RNA and proteins, which undergoes dynamic changes in RNA-RNA, RNA-protein,
and protein-protein interactions during the splicing reaction. Recent years have seen progress in functional
and structural analyses of the splicing machine and its subcomponents, and this review is focused on struc-
tural aspects of the pre-mRNA splicing machine and their mechanistic implications on the splicing of multi-
intronic pre-mRNAs. It brings together, in a comparativemanner, structural information on spliceosomes and
their intermediates in the stepwise assembly process in vitro, and on the preformed supraspliceosomes,
which are isolated from living cell nuclei, with a view of portraying a consistent picture.Introduction
Eukaryotic pre-mRNAs are transcribed in the cell nucleus by
RNA polymerase II (pol II), and must undergo several posttran-
scriptional modifications before their export to the cytoplasm
as functional mRNAs. These processing events include 50-end
capping, 30-end processing, splicing, and editing. Most pre-
mRNAs contain intervening sequences (introns) that must be
removed in order to place the coding sequences (exons) in a
protein-reading frame. The precise removal of introns from pre-
mRNAs by the pre-mRNA splicing machine is, therefore, an es-
sential step in the regulation of gene expression. Themechanism
of the chemical transformations involved in this critical process-
ing event, known as pre-mRNA splicing, has been extensively
worked out based on studies in vitro, mainly of pre-mRNAs com-
posed of two exons and an intervening intron (Brow, 2002; Burge
et al., 1999;Will and Lu¨hrmann, 2006). However, the regulation of
splicing and alternative splicing of the multi-intronic pre-mRNAs
transcribed in vivo is still not well understood, particularly from
the standpoint of the structure-function relationship of the spli-
ceosome—the macromolecular machine that catalyzes the
splicing reactions. A large body of literature describing high-res-
olution structures of individual components and domains of the
spliceosome has been published and reviewed (Auweter et al.,
2006; Clery et al., 2008; Stefl et al., 2005). This review is focused
on the overall architecture of the pre-mRNA splicing machine,
though at a lower resolution, emphasizing the implications of
its structural aspects on the mechanism of the process itself.
Splicing and Spliceosome Assembly In Vitro
The accuracy and efficiency of pre-mRNA splicing is attributed
to a number of trans-acting factors, which include the five spli-
ceosomal small nuclear ribonucleoprotein complexes (U1, U2,
U4, U5, and U6 snRNPs) (Tycowski et al., 2006) and several
non-snRNP protein splicing factors, as well as to cis-acting se-
quence elements. The latter include 50 and 30 splice sites,Structurea branch point, and a polypyrimidine tract. Splicing enhancers
and silencers are additional control elements that play an impor-
tant role in both constitutive and alternative splicing, by interact-
ing with the serine/arginine-rich (SR) protein splicing factors
(Bourgeois et al., 2004; Sanford et al., 2005).
Studies in vitro revealed that RNA splicing proceeds through
a mechanism involving two trans-esterification reactions
(Figure 1). It occurs in the spliceosome, a dynamic machine
that undergoes several changes in interactions and conforma-
tions. The assembly of the 60S spliceosome in vitro occurs in
a stepwise manner (reviewed in Brow, 2002; Will and Lu¨hrmann,
2001, 2006). This process involves a series of interactions among
the five major snRNPs, as well as a number of non-snRNP splic-
ing factors, which are dynamically recruited to the spliceosome
when an exogenous pre-mRNA is added to a crude nuclear ex-
tract. The spliceosomal snRNPs participate in splice-site recog-
nition and thus play an essential role in splicing through cooper-
ative RNA-RNA interactions between the snRNAs themselves
and with the pre-mRNA (Brow, 2002; Burge et al., 1999; Staley
and Guthrie, 1998; Tycowski et al., 2006).
Density gradient centrifugation and native gel electrophoresis
revealed at least four intermediate complexes (E, A, B, and C) in
the assembly process in vitro of the major class of spliceosomes
(U2spliceosomes) (Figure2).For thecatalytic activationof thespli-
ceosome, complex B undergoes a structural change, forming an
intricate network of interactions between U6 and U2 snRNAs
with the pre-messenger RNAmolecule, which together constitute
part of the catalytic core of the spliceosome. The activated com-
plex B undergoes the first catalytic step of splicing, which gener-
ates complex C. Complex C undergoes the second catalytic
step, after which the postspliceosomal intron-containing complex
is dismantled and the mRNA product is released (Nilsen, 1998;
Staley and Guthrie, 1998). A minor group of spliceosomes (U12
spliceosomes), composedofU11,U12,U4atac,U6atac (replacing
U1, U2,U4, andU6snRNPs, respectively), U5 snRNP, and several16, November 12, 2008 ª2008 Elsevier Ltd All rights reserved 1605
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U12-specificciselementsat thepre-mRNA(Tycowskietal., 2006).
Recent molecular and genetic studies emphasized the impor-
tance of conformational changes within the spliceosome for
splicing regulation and quality control during the splicing pro-
cess. These studies also highlighted the role of RNA helicases
in controlling the fidelity of the splicing reaction (Mayas et al.,
2006; Query and Konarska, 2006; Staley and Guthrie, 1998;
Valadkhan, 2007), and revealed the existence of mutually incom-
patible conformational states of the active site during the two
steps of splicing (Konarska et al., 2006; Rhode et al., 2006). Al-
though such remodeling of the spliceosome is likely to be con-
trolled by an extensive and dynamic network of protein-protein,
RNA-RNA, and protein-RNA interactions, these transitions, as
discussed below, do not necessarily require large-scale struc-
tural changes (namely, changes in the overall shape of the com-
plex), but can be accounted for by local conformational changes
(Nilsen, 1998; Rhode et al., 2006; Valadkhan, 2007).
Structural Studies of Spliceosomes and Their
Subcomponents Assembled In Vitro
X-ray andNMRStudies of Spliceosomal Subcomponents
In terms of resolution and accuracy, X-ray crystallography is
highly instrumental for understanding molecular architectures.
Nevertheless, the use of this technique for structural studies of
large biological complexes, such as the mega-Dalton splicing
complexes, is hampered by the requirements for large quantities
of homogenous material. Therefore, the high-resolution struc-
tures that have thus far been resolved in the splicing field by
X-ray and NMR are confined to individual proteins or to spliceo-
somal domains rather than to the larger assembled complexes
(reviewed in Auweter et al., 2006; Clery et al., 2008; Stefl et al.,
2005). Highlights of this literature are described in this review
Figure 1. Mechanism of RNA Splicing
First step: The 20 hydroxyl of a specific adenosine base at the branch site of
a pre-mRNA becomes nucleophilic and makes a nucleophilic substitution
type 2 (SN2) attack on the phosphodiester moiety at the 50 splice site (marked
in red). Two intermediates are formed: the 50 exon in a free form (red) and the 30
exon-intron moiety in a lariat form. Second step: In a second SN2-type reac-
tion, the free 30 hydroxyl anion of the 50 exon attacks the phosphodiester moi-
ety at the 30 splice site (marked in blue) to yield the spliced RNA and the
spliced-out intron in a lariat form.1606 Structure 16, November 12, 2008 ª2008 Elsevier Ltd All rightswhen relevant to its main focus, which addresses the structural
analysis of larger and functional splicing complexes.
The spliceosomal snRNAs constitute a key element in the
functioning of the splicing machine, and their small sizes make
them amenable to NMR studies. Butcher and colleagues have
solved several of U snRNA structures, with emphasize on U2
and U6 snRNAs in light of their proposed role in catalysis (Blad
et al., 2005; Butcher and Brow, 2005; McManus et al., 2007;
Sashital et al., 2007). An important aspect of U2 snRNA function
is its base-pairing interaction with the pre-mRNA branch site,
which positions a bulged adenosine to serve as the nucleophile
in the first chemical step of pre-mRNA splicing. In accordance
with this proposed mechanism, X-ray (Lin and Kielkopf, 2008)
and NMR (Newby and Greenbaum, 2002) structures of RNA
oligonucleotide duplexes composed of the pseudouridylated
U2 snRNA and the branchpoint consensus sequences, revealed
an extrahelical adenosine at the adenosine branch point.
Protein-RNA and protein-protein interactions also underlie the
structure and function of the splicing machine. One of the most
common protein-folds that mediate protein-RNA interactions is
the RNA recognition motif (RRM), also termed RNA binding do-
main (RBD). Structural analyses by X-ray crystallography and
NMR helped provide a molecular basis for the RRM-RNA recog-
nition. The dual ability of proteins with this motif to interact both
with proteins and RNA plays a key role in splicing. Structural
studies suggest that the surface exposed to the RNA could de-
termine whether an interaction occurs. This is in accordance
with the observed variations of sequence specificity in different
interactions (reviewed in Clery et al., 2008; Maris et al., 2005).
Figure 2. Schematic Presentation of the Stepwise Spliceosome
Assembly Pathway In Vitro
When pre-mRNA is added to a crude nuclear extract of cells (color code as in
Figure 1) complex E is formed by the binding of U1 snRNP (green) to the 50
splice site of the pre-mRNA. Complex A is then formed by an ATP-dependent
interaction of U2 snRNP with the branch site. Addition of the U4/U6.U5 tri-
snRNP gives rise to complex B. This step is followed by the release of the
U1 and U4 snRNPs and the remodeling of complex B to yield the splicing-ac-
tive complex C. For simplification, binding of hnRNP, SR, and other spliceoso-
mal proteins to various cis-acting elements of the pre-mRNA, which occur
during the splicing reaction, are not shown.reserved
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Three-dimensional image reconstruction of spliceosomal snRNPs by EM
single-particle technique. Bar represents 10 nm.
(A) U1 snRNP (Stark et al., 2001)
(B) U4/U6 snRNPs (Sander et al., 2006)
(C) U5 snRNP (Sander et al., 2006)
(D) U4/U6.U5 tri-snRNP (Sander et al., 2006)Each of the U1, U2, U4, and U5 snRNPs share a common core
of a heptameric Sm protein complex, which is bound as a ring-
shaped structure to an Sm binding sequence in the respective
snRNA (Kambachet al., 1999). A similar heptameric ringcomplex,
termed like-Sm (LSm), binds to a specific site in the U6 snRNA
(Will and Lu¨hrmann, 2001). In addition, each snRNPcontains spe-
cificproteins, as revealedbybiochemical analysesandconfirmed
bymass spectrometry (MS) (Will and Lu¨hrmann, 2001). The struc-
tureof theRBD1domainofU1A,oneof thespecificproteinsof the
U1 snRNP, was solved either in the presence of a 21-nt RNA hair-
pin at a resolution of 1.92 A˚ (Oubridge et al., 1994), or by NMR (Lu
and Hall, 1997) and by X-ray crystallography as a free domain at
a resolution of 1.8 A˚ (Rupert et al., 2003). In the case of U2 snRNP,
the structure of several protein-RNA and protein-protein com-
plexes has been studied. U2B00-U2A0 in a ternary complex with
stem loop IV of U2 snRNA has been resolved by X-ray crystallog-
raphy (Price et al., 1998). Also, the U2 snRNP-specific protein
P14.SF3b has been partially resolved both by X-ray crystallogra-
phy (Schellenberg et al., 2006) and NMR (Kuwasako et al., 2007).
The U2 auxiliary factor proteins U2AF65 and U2AF35 are re-
quired for the binding of U2 snRNP to the pre-mRNA. Structural
studies of subcomplexes representing interactions of these
proteins include the following: (i) a complex between the central
domain of U2AF35 and the proline-rich region of U2AF65 (Kielkopf
et al., 2001); (ii) individual RBD domains of U2AF65 by NMR (Ito
et al., 1999) and by X-ray crystallography (Thickman et al.,
2007); (iii) U2AF65 RBD complexed with splicing factor SF1
(Selenko et al., 2003) and the binding of SF1 to the branch point
(Liu et al., 2001); and (iv) U2AF65 RBD complexed with a hepta-
meric uridine RNA oligonucleotide (Sickmier et al., 2006). These
studies showed that U2AF65 makes an unusual number of RNA
contacts via intervening water molecules and flexible side
chains, which enable its binding to different, including poorly
conserved, polypyrimidine-tract sequences.
Structural studies of subcomponents of U5.U4/U6 tri-snRNP
were also performed. The structure of the U5 snRNP 15K-
specific protein was reported at a resolution of 1.4 A˚ (Reuter
et al., 1999), aswas its structure in complex with theGYF domain
of U5 snRNP 52K protein (Nielsen et al., 2007). The structure
of cyclophilin H complexed with a peptide derived from the
U4/U6 60K-specific protein revealed a novel protein-protein in-
teraction (Reidt et al., 2003). Finally, the structure of U5.U4/U6
15.5K-specific protein in the presence of the 50-end stem loop
of U4 snRNA has been elucidated (Vidovic et al., 2000).
Structures of wild-type and mutant Prp (precursor RNA
processing) proteins were reported mainly in yeast (Prp 19 [Van-
der Kooi et al., 2006]; Prp 24 [Bae et al., 2007];WWdomain of Prp
40 bound to Prp8 [Wiesner et al., 2002]; mutant Prp 18 [Jiang
et al., 2000]). Studies of mutations and comparisons betweenStructuredifferent organisms revealed interesting information about
mechanism. A typical example is the C-terminal domain of Prp
8, whose structure was resolved in both yeast (Pena et al.,
2007) and Caenorhabditis elegans (Zhang et al., 2007). Both
studies show that the C-terminal domain is involved in protein-
protein interaction. Mutations in the C-terminal domain of human
Prp8 are linked to the RP13 form of retinitis pigmentosa, and
they also disrupt its interaction with Brr2 and Snu114. Thus, it
has been proposed that dysfunction of this protein-protein plat-
formmight underlie a plausible molecular explanation for retinitis
pigmentosa (Pena et al., 2007).
SR proteins constitute an important component of the non-
snRNP protein splicing factors. Known to be involved in regulat-
ing and selecting splice sites, SR proteins play a key role in alter-
native splicing (Bourgeois et al., 2004). The structures of theRRM
of SRp20 and 9GB, as well as the structure of the RRM of SRp20
in complex with 4 nt RNA sequence (50CAUC30), have been
solved (Hargous et al., 2006). The latter structure revealed that
only the 50 cytosine is recognized in a specific way. The structure
of RRM2 of ASF/SF2 bound to RNA revealed a new way of bind-
ing to theRNA (Tintaru et al., 2007). Thepolypyrimidine tract bind-
ing protein (PTB) involved in splicing regulation and alternative
splicing and in multiple aspects of RNA processing is composed
of four RRMs; the structure of each with and without RNA was
solved, providing insight into its diverse functional roles (reviewed
in Auweter andAllain, 2008). The structure of UAP56, an essential
splicing factor andmRNA export factor, was solved at 1.9 A˚. The
structure of thisDExD/H-boxprotein suggests that it possesboth
helicase and ATPase activities (Zhao et al., 2004). These struc-
tures are highlighted examples of available high-resolution infor-
mation on individual spliceosomal components that reveal partial
interactions, which might be further incorporated into lower-res-
olution structures of larger complexes.
Structural Studies of Spliceosomal snRNPs
by Cryo-Electron Microscopy
High-resolution structural information is not yet available for any
of the splicing complexes. Nevertheless, cryo-electron micros-
copy (cryo-EM) has been instrumental in the three-dimensional
(3D) image reconstruction of certain splicing subcomplexes,
though at a lower resolution (Stark and Lu¨hrmann, 2006). Figure 3
depicts structures of four snRNP complexes, all drawn to the
same scale for size comparison.
U1 snRNP is the smallest spliceosomal snRNP. It is composed
of U1 snRNA, the seven Sm proteins, and three specific proteins
(U1-A, U1-70K, and U1-C). Its 3D structure was determined by
cryo-EM single-particle technique at a resolution of 10 A˚ (Stark
et al., 2001) (Figure 3A). U2 snRNP consists of U2 snRNA, the
seven Sm proteins, and about 15 U2-specific proteins, grouped16, November 12, 2008 ª2008 Elsevier Ltd All rights reserved 1607
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Different views of a surface representation of in vitro-assembled complex C, reconstructed at 30 A˚ resolution from cryonegatively stained images and contoured
to an estimated mass of 2.6 MDa (Jurica et al., 2004). Bar represents 10 nm.in splicing factor 3a and 3b (SF3a andSF3b), which assemble se-
quentially to form the U2 snRNP (Stark and Lu¨hrmann, 2006).
The structure of U2 snRNP has not yet been determined, but
the structure of SF3bwas determined by cryo-EM single-particle
technique at 10 A˚ resolution (Golas et al., 2003). U11/U12
di-snRNP is part of the minor spliceosome. Although U11 and
U12 snRNPs are functionally equivalent to U1 and U2 snRNPs
in the major spliceosome, they differ from the two latter com-
plexes in that they form a stable complex, whereas U1 and U2
snRNPs do not. The U11/U12 di-snRNP share with U2 snRNP
the seven SF3b proteins, whereas most of the other proteins
are different. Cryo-EM structural analyses of U11/U12 di-snRNP
at 12 A˚ resolution revealed that in order to accommodate the
structure of SF3b within the structure of U11/U12 di-snRNP,
the structure of the former has to undergo major conformational
changes (Golas et al., 2005). With respect to size and mass, the
U5 snRNP is a major component of the spliceosome. The human
20S U5 snRNP consists of the U5 snRNA, seven Sm proteins,
and nine U5 snRNP-specific proteins (reviewed in Will and
Lu¨hrmann, 2006). Structural analysis of U5 snRNP at
26–32 A˚ resolution by cryonegative staining revealed a triangular
structure (Sander et al., 2006) (Figure 3C). The U4/U6.U5
tri-snRNP complex contains the U4/U6 and U5 snRNAs and
29 distinct proteins (reviewed in Will and Lu¨hrmann, 2006).
Structural analyses by cryo-EM at 19–24 A˚ resolution revealed
elongated triangular particles (Sander et al., 2006) (Figure 3D).
Structural analysis of U4/U6 di-snRNP at 40 A˚ resolution
showed two distinct globular domains connected by a bridge
(Sander et al., 2006) (Figure 3B).
Intermediate Splicing Complexes Assembled In Vitro
Three-dimensional reconstructions of a number of intermediates
in the pathway of the spliceosome assembly in vitro were per-1608 Structure 16, November 12, 2008 ª2008 Elsevier Ltd All rightsformed. To allow comparison between these structures (Figures
4–6) and the structure of the native spliceosome, which is dis-
cussedbelow (Figure7), all structuresaredrawn to thesamescale.
TheC-complex spliceosome,which contains three of the five spli-
ceosomal U snRNPs (U2, U5, and U6 snRNPs), was resolved at
a resolution of 30 A˚ using cryonegative staining and the sandwich
method (Jurica et al., 2004). The 27 3 22 3 24 nm structure re-
vealed three major domains, at a threshold that accentuates the
division into domains (Figure 4). The structure of a U5.U2/U6 spli-
ceosome complex from fission yeast was resolved by cryo-EM
single-particle technique at a resolution of 29 A˚ (Ohi et al.,
2007) (Figure 5). This complex, which sedimented at 37S, was
obtained by tandem affinity purification under nonphysiological
conditions. Mass measurements by scanning transmission elec-
tron microscopy (STEM) revealed a mass of 2.0 MDa, yet the
cumulative mass of proteins identified by MS analysis of this
complex revealed a mass of 3.0 MDa (Ohi et al., 2002). A better
agreement with the measured mass was obtained by summing
up the masses of U2, U5, and U6 snRNPs and the nineteen com-
plex (NTC), found in this splicing complex, which gave a mass of
2.2 MDa. The structure of the U5.U2/U6 spliceosome complex
depicts distinct domains that contact each other at the center
of the complex, with an overall dimension of 30 3 20 3 18 nm
(Ohi et al., 2007). The structure of this complex is similar to that
of the in vitro-assembled mammalian complex C (Figure 4).
The structure of the precatalytic spliceosomal complex B
lacking the U1 snRNP (BDU1) was solved at a resolution of
40 A˚ using cryonegative staining and the sandwich method
(Boehringer et al., 2004). The 3D reconstruction revealed
a structure with a flexible head domain. The structure, having
maximal dimensions of 37 3 27 3 17 nm, is more extended
in one direction and narrower in a perpendicular direction
(Figure 6). Comparison of the structure of BDU1 with that ofFigure 5. Structure of Schizosaccharomyces pombe U5.U2/U6 Splicing Complex
Different views of a surface representation of the S. pombe U5.U2/U6 splicing complex, reconstructed at 29 A˚ resolution from cryoimages and contoured to
a STEM-measured mass of 2.0 MDa (Ohi et al., 2007). Bar represents 10 nm.reserved
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BDU1
Different views of a surface representation of in vitro-as-
sembled complex BDU1, reconstructed at 40 A˚ resolution
from cryonegatively stained images and contoured to an
estimated mass of 5.5 MDa (Boehringer et al., 2004). Bar
represents 10 nm.tri-snRNP led the authors to suggest that tri-snRNP is placed at
the lower triangular domain of BDU1. Analysis of negatively
stained spliceosomal A complex at 40–50 A˚ resolution was re-
cently performed (Behzadnia et al., 2007). This complex, iso-
lated by double-affinity purification, contained the U1 and U2
snRNPs and had an asymmetric shape structure with overall
dimensions of 23 3 20 3 19.5 nm.
Splicing Complexes Isolated from Intact Mammalian
Cells—Supraspliceosomes
Isolation of Supraspliceosomes
An alternative, top-down approach for the isolation of physiolog-
ically significant splicing complexes from mammalian cell nuclei
was initiated by Sperling et al. (1985). Isolation conditions were
optimized whereby over 85% of 3H-labeled pol II transcripts
could be released to a nuclear supernatant. Fractionation of
such nuclear supernatants in sucrose or glycerol gradients
revealed that the labeled pol II transcripts sedimented at the
200S region in the gradient (Sperling et al., 1985). Visualization
by EM of aliquots from fractions across the gradient revealed
a peak of large tetrameric structures, having overall dimensions
of 503 50 nm (Figure 8A), which cosedimented at 200S with the
peak of the 3H-labeled pol II transcripts (Spann et al., 1989).
Analyses of the distribution across the gradient of specific RNA
transcripts (e.g., CAD, DHFR, and actin), as well as of the general
population of the nuclear polyadenylated RNAs, showed
that they all sedimented at the 200S region (Spann et al., 1989;
Sperling et al., 1985). These 200S complexes, initially called
large nuclear RNP complexes, were termed supraspliceosomes.
Supraspliceosomes were shown to contain all five spliceoso-
mal snRNPs as integral components of the complex (Miriami
et al., 1995; Sperling and Sperling, 1998; Yitzhaki et al., 1996),
as well as a large number of non-snRNP protein splicing factors
(Miriami et al., 1995; Sperling and Sperling, 1998; Yitzhaki et al.,
1996). It is physiologically significant that all phosphorylated SR
proteins, which are required for spliceosome assembly and alter-
native splicing, are predominantly associated within the supra-
spliceosome (Yitzhaki et al., 1996). A remarkable feature of
supraspliceosomes is that they package pre-mRNA transcripts
of different sizes and of different number of introns into com-
plexes of a unique size and hydrodynamic properties, indicating
their universal nature (Azubel et al., 2006; Miriami et al., 1994;
Spann et al., 1989; Sperling et al., 1997; Sperling and Sperling,
1998; Yitzhaki et al., 1996).
Structural Studies of the Supraspliceosome
The complexity and large size of the supraspliceosome made
EM themethod of choice for its structural analysis. Three-dimen-Structuresional image reconstruction of individual supraspliceosomes by
automated electron tomography of negatively stained (Sperling
et al., 1997) and of frozen hydrated complexes (Medalia et al.,
2002) showed the supraspliceosome as forming a closed struc-
ture, 50 3 50 3 35 nm in size, composed mainly of four similar
subcomplexes. Mass measurements by STEM showed that
the supraspliceosome has a mass of 21 MDa, and each of its
main subcomplexes has a mass of 4.8 MDa (Mu¨ller et al.,
1998). Further STEM and cryo-EM studies revealed that the
subcomplexes of the supraspliceosome are interconnected,
presumably by the pre-mRNA (Medalia et al., 2002; Mu¨ller
et al., 1998). These observations led to the working hypothesis
that each supraspliceosome packs one pre-mRNA and can
therefore be responsible for its posttranscriptional processing,
where each of its four major subcomplexes represents a spliceo-
some that can splice the intron wound around it.
Isolation and Characterization of Native Spliceosomes
The four subcomplexes of the supraspliceosome are intercon-
nected in a flexible way and may thus adopt different angular
settings, which impose a significant restriction on reaching
high resolution in EM image analyses. Therefore, a method
was developed to prepare and isolate the monomeric spliceoso-
mal subcomplexes from supraspliceosomes, by specific cleav-
age of the general population of pre-mRNAs, while keeping the
snRNAs within these subcomplexes intact (Azubel et al., 2004,
2006). The resulting complexes were purified by centrifugation
in a glycerol gradient, where they sedimented at the 60–70S
region (Azubel et al., 2006). Northern blot analysis revealed
that, like the supraspliceosome, the subcomplexes contained
the full complement of the five spliceosomal snRNAs (Azubel
et al., 2006). Importantly, the subcomplexes and supraspliceo-
somes were functional in splicing (Azubel et al., 2006). Hence,
the subcomplexes were termed native spliceosomes.
Structural Analysis of Native Spliceosomes
by the Cryo-EM Single-Particle Technique
The isolation of native spliceosomes and their relative stability en-
abled their 3D cryo-EM structural analysis by the single-particle
technique at a resolution of 20 A˚ (Azubel et al., 2004) (Figure 7).
The structure revealed an elongated globular particle made up of
two distinct subunits. This finding is consistent with previous
STEM mass measurements, which revealed two major, equally
populated, distinct groups of small particles with masses of
1.5 MDa and 3.1 MDa, which together are close in mass to the
4.8MDa native spliceosome (Mu¨ller et al., 1998). The two subunits
are interconnected with a tunnel running between them, which is
large enough to allow the pre-mRNA to pass through. The other16, November 12, 2008 ª2008 Elsevier Ltd All rights reserved 1609
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Different views of a surface representation of the native spliceosome reconstructed at 20 A˚ resolution from cryoimages (Azubel et al., 2004). The structure
was contoured to a STEM-measured mass of 4.8 MDa (Mu¨ller et al., 1998). In the right panel, high-threshold rendering (blue surface) shows the high-density
mass region, which represents the stable RNAs within the structure of the native spliceosome. The large subunit of the native spliceosome is thus a suitable
candidate to harbor the five spliceosomal snRNPs. Adapted from Azubel et al. (2004). Bar represents 10 nm.side of the native spliceosome exposes a cavity that could provide
a place to transiently store the pre-mRNA. The large subunit was
shown tobeasuitablecandidate toaccommodate thefivespliceo-
somal snRNPs, because the high density regions were confined
to the large subunit (Figure 7, far right image) (Azubel et al., 2004).
Organization of the Native Spliceosomes
within the Supraspliceosome
To address how the native spliceosomes are arranged within the
intact supraspliceosome, EM structural analysis and reconstruc-
tion of the native spliceosomes in the context of the intact parti-
cle was performed. It was shown that the small subunits reside in
the center of the supraspliceosome and their edges form a right
angle, thus facilitating close contacts between the small subunits
generating a four-fold pattern (Figure 8B) (Cohen-Krausz et al.,
2007). A good correlation was obtained between the structure
of the isolated native spliceosome, solved by cryo-EM (Azubel
et al., 2004), and that of the native spliceosome within the intact
supraspliceosome (Cohen-Krausz et al., 2007).
Biological Significance of the Supraspliceosome
Is the tetrameric structure of the supraspliceosome biologically
significant? Due to the particular mode of organization of the
supraspliceosome into a large multicomponent structure, it can
be regarded as a biological self-assembly system. Whereas var-
ious oligomeric forms of such systems may be observed under
non-physiological conditions; under physiological conditions,
the biologically relevant active macromolecular complex pre-
vails. Furthermore, when a biological self-assembly system is
composed of nucleic acids and proteins, not only that the biolog-
ically relevant complex prevails under physiological conditions,
but it requires the presence of both the nucleic acid and protein
components. In this context, it is important to note that supraspli-
ceosomes were isolated under physiological conditions, and the
pre-mRNA was shown to be essential for their assembly (Spann
et al., 1989; Sperling et al., 1985). Namely, when the pre-mRNA
was cleaved, supraspliceosomes irreversibly dissociated into
native spliceosomes (Azubel et al., 2006). Furthermore, the iso-
lated supraspliceosomes were shown to be functional (Azubel
et al., 2006). Additional important information, although seem-
ingly circumstantial, is in support of the notion that the supraspli-
ceosome is a biologically significant entity. (i) Specific pre-mRNA
transcripts, as well as their splicing intermediates and fully1610 Structure 16, November 12, 2008 ª2008 Elsevier Ltd All rightsspliced RNAs, prevail in supraspliceosomes (Miriami et al.,
1994; Spann et al., 1989; Sperling and Sperling, 1998; Sperling
et al., 1985). (ii) Supraspliceosomes harbor all known splicing
factors; particularly, the phosphorylated forms of the SR protein
are predominantly associated with tetrameric supraspliceo-
somes (Yitzhaki et al., 1996). (iii) STEM mass measurements
revealed a relatively uniform mass for the supraspliceosome
(21.1 ± 1.6 MDa; n = 400), and for the native spliceosome (4.8 ±
0.5; n = 510) (Mu¨ller et al., 1998). Further support for the concept
of a biologically significant supraspliceosomal complex was in-
ferred from a study showing that U2/U6 snRNA base pairing,
which characterizes active spliceosomes assembled in vitro,
were found in complexes sedimenting between 150S and 300S
but not in 60S complexes (Wassarman and Steitz, 1993). Also,
analysis of pol II transcripts in situ, in cells grown in tissue culture,
revealed that they are assembled in supraspliceosomes (Iborra
et al., 1998).
Comparison of Splicing Complexes Assembled In Vitro
and In Vivo
Splicing complexes assembled in vitro and in vivo are both highly
dynamic macromolecular complexes that undergo several con-
formational changes and alterations in RNA-RNA, protein-RNA,
and protein-protein interactions during the splicing reaction.
With respect to mass and dimensions, the fully in vitro-assem-
bled 60S spliceosome appears to be similar to the native
spliceosome, which is derived from the in vivo-assembled tetra-
meric supraspliceosome. Although the mass of the 60S in vitro-
assembled spliceosome has not yet been directly determined,
the structure of the splicing complex BDU1 (Boehringer et al.,
2004) was presented using extreme threshold that enclosed
a volume that corresponded to either 6.5 or 4.5 MDa. The
authors then proposed that 5.5 MDa (the averaged mass) corre-
sponded to the mass of the splicing complex BDU1. Another es-
timate, based on sedimentation velocity of the 60S spliceosome,
gave 4.9MDa (Mu¨ller et al., 1998). In comparison, themass of the
native spliceosome, directly measured by STEM, is 4.8 MDa
(Mu¨ller et al., 1998). In this respect, the supraspliceosome could
be regarded as being composed of four spliceosomes. Yet, the
complexes assembled in vivo differ from those assembled
in vitro in at least two conceptual aspects: one pertains to their
assembly pathway, the other pertains to the way they are
expected to splice multi-intronic pre-mRNAs.reserved
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ReviewFigure 8. Electron Microscopy of the Supraspliceosome
(A) A gallery of EM images of supraspliceosomes each composed of four subcomplexes—native spliceosomes. Bar represents 20 nm.
(B) Intact supraspliceosomes were classified by Correspondence Analysis and Hierarchical Ascendant Classification. One of the classes is depicted showing the
close contact between neighboring substructures in the center of the supraspliceosome. Adapted from Cohen-Krausz et al. (2007). Bar represents 10 nm.The assembly of the spliceosome in vitro was shown to pro-
ceed in a stepwise manner (Brow, 2002; Staley and Guthrie,
1998), whereas the assembly of newly transcribed pre-mRNAs
into supraspliceosomes in vivo appeared to involve preformed
complexes (Azubel et al., 2006; Iborra et al., 1998; Stevens
et al., 2002). Furthermore, the assembly pathway in vitro is char-
acterized bymajor changes in composition (e.g., only three of the
five spliceosomal snRNPs are part of the active C complex).
However, both the supraspliceosome and the native spliceo-
some contain all five spliceosomal snRNPs (Azubel et al.,
2006). This finding, together with the ability to isolate a functional
‘‘penta-snRNP’’ complex from yeast (Stevens et al., 2002), fur-
ther highlights the important role of large, preformed complexes
in pre-mRNA splicing in vivo. The apparent discrepancy between
the notion of a stepwise assembly pathway of the spliceosome
in vitro and the occurrence of a preformed splicing complex
in vivo has been explained by a ‘‘holospliceosome’’ model, in
which the sequential complexes represent ordered modulations
within the in vivo-assembled spliceosome without the loss of
components (Brow, 2002). It has also been pointed out that
such distinct complexes, which represent intermediate states
in spliceosome assembly in vitro, may not occur in vivo (Nilsen,
2002; Stevens et al., 2002).
The assembly pathways of supraspliceosomes in vivo and that
of spliceosomes assembled in vitro also differ in the sense that
the former occurs cotranscriptionally in the nucleus, whereas
the assembly process in vitro occurs when a full-length pre-
mRNA is interacting with the spliceosomal components present
in a nuclear extract. We suggest that these two likely distinct
pathways might lead to different local minima in the respective
free energy profiles, which could result in the assembly of slightly
different complexes. Alternatively, the observed changes in
composition between intermediate complexes assembled
in vitro, which are not found in native spliceosomes and supra-
spliceosomes, might be due to the lack of specific components
present in native spliceosomes, which help keep the latter
particles together. In this context it should be noted that theStructurein vitro-assembled splicing complexes were usually isolated in
the presence of heparin, which could have caused partial disso-
ciation of components (Deckert et al., 2006) (e.g., the splicing
complex BDU1 was isolated in the presence of heparin [Boeh-
ringer et al., 2004], whereas U1 snRNP was included in complex
B when heparin was omitted [Deckert et al., 2006]).
Analysis by MS of several of the in vitro-assembled splicing
complexes and their subcomplexes yielded a large arsenal of
proteins, some of which were already identified as splicing fac-
tors and some of which are new (reviewed in Jurica and Moore,
2003; Nilsen, 2003; Will and Lu¨hrmann, 2006). Yet, the cumula-
tive mass of proteins found by MS in the splicing complexes
highly exceeds the respective estimated or measured mass of
these complexes (see above), indicating that further refinement
of the MS results is required. Recently, MS analyses of
complexes isolated from HeLa cells by a modification of the
supraspliceosome protocol (Miriami et al., 1994) revealed over
300 proteins, including a large number of splicing factors and
also several proteins not found in spliceosomes assembled
in vitro (Chen et al., 2007). It is reassuring that most of the pro-
teins identified as components of the supraspliceosome (Rait-
skin et al., 2001, 2002; Sperling and Sperling, 1998; Yitzhaki
et al., 1996) were validated through these MS analyses. How-
ever, further analyses of well-defined high-quality preparations
are necessary to obtain amore accurate picture of the supraspli-
ceosome proteome.
Because the stepwise assembly pathway of the spliceosome
in vitro involves major changes in composition, it could have
been assumed that the changes in interactions that occur within
this complex during the splicing reaction involve major structural
rearrangements. However, such compositional changes were
not found in supraspliceosomes and native spliceosomes. It is
therefore plausible that the changes in base-pairing interactions
within the native spliceosome are likely accompanied by less
dramatic global structural changes than anticipated, and with
less dramatic compositional changes than those found in the
in vitro-assembled spliceosome. In support of this notion is the16, November 12, 2008 ª2008 Elsevier Ltd All rights reserved 1611
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ReviewFigure 9. The Supraspliceosome Model
Schematic models of the supraspliceosome in which the pre-mRNA (introns in blue, exons in red) is connecting four native spliceosomes. The supraspliceosome
presents a platform onto which the exons can be aligned and splice junctions can be checked before splicing occurs.
(A) The pre-mRNA that is not being processed is folded and protected within the cavities of the native spliceosome.
(B) When a staining protocol that allows visualization of nucleic acids was used, RNA strands and loops were seen emanating from the supraspliceosomes (Mu¨ller
et al., 1998). Under these conditions the RNA kept in the cavity is proposed to unfold and loop-out. In the looped-out scheme an alternative exon is depicted in the
upper left corner. From Azubel et al. (2006). Bar represents 10 nm.fact that the structure of the native spliceosome was determined
by cryo-EM single-particle technique at a resolution of 20 A˚ (Azu-
bel et al., 2004), suggesting that the structural changes that oc-
cur in vivo are more subtle than those that could be resolved at
this resolution.
Splicing of Multi-intronic Pre-mRNAs
Most of our knowledge of the biochemistry and mechanism of
splicing has been derived from studies on spliceosomes assem-
bled in vitro on pre-mRNAs comprising one intron flanked by two
exons. Yet, because the majority of mammalian pre-mRNAs are
multi-intronic, it can be anticipated that in mammalian cell nuclei
the pre-mRNAs would be assembled in multi-spliceosome com-
plexes. Therefore, the finding that splicing complexes isolated
from live mammalian cells are assembled in supraspliceosomes
is not surprising, and it is reassuring that the native spliceo-
some—the building block of these structures—resembles the
in vitro-assembled spliceosome.
Alternative splicing, whereby different combinations of exons
are spliced together to produce different mRNAs from a single-
copy gene, should also be considered in the context of the struc-
ture-function relationship of the splicing machine. It has been
estimated that 40%–75% of the25,000 human genes undergo
alternative splicing, thereby increasing the coding potential of
the human genome by more than one order of magnitude (Brett
et al., 2002; Garcia-Blanco et al., 2004; Modrek and Lee, 2002;
Srebrow and Kornblihtt, 2006). Regulated splicing, as well as1612 Structure 16, November 12, 2008 ª2008 Elsevier Ltd All rightsconstitutive splicing, operates through the combinatorial inter-
play of positive and negative regulatory signals present in the
pre-mRNA, which are recognized by trans-acting factors, the
most studied of which are members of the hnRNP and SR
protein families (Bourgeois et al., 2004; Sanford et al., 2005).
To account for the necessity to splice multi-intronic pre-
mRNAs, a modular multispliceosome model that extrapolates
from the in vitro-assembled spliceosome has been implied in
the published literature. Namely, a pre-mRNA having N introns
would require N spliceosomes for its processing. Such a model
can account for splicing regulation within each individual spli-
ceosome, taking advantage of the interplay between splicing
factors and the respective cis elements they recognize. Yet,
this model does not explain how splicing regulation and commu-
nication between spliceosomes, as well as quality control of
multi-intronic transcripts, might be achieved.
The supraspliceosome, by contrast, presents a closed-struc-
ture model composed of four native spliceosomes connected by
the pre-mRNA. A critical experiment in support of this arrange-
ment showed that cleavage of the pre-mRNA yielded functional
native spliceosomes that could be reconstituted into supraspli-
ceosomes by incubation with exogenously added pre-mRNAs
(Azubel et al., 2004, 2006). In this configuration, the supraspli-
ceosome acts as a multiprocessor machine that can simulta-
neously splice four introns—not necessarily in a consecutive
manner (Figure 9). In this schematic model, which was based
on structural studies (Azubel et al., 2004, 2006; Cohen-Krauszreserved
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the supraspliceosome is presented by the 20-A˚ resolution struc-
ture of the native spliceosome (Azubel et al., 2004). The small
subunit of each native spliceosome, proposed to harbor non-
snRNP components such as SR proteins and hnRNP proteins,
is placed at the center of the supraspliceosome (Cohen-Krausz
et al., 2007). This configuration allows communication between
the native spliceosomes, which is a crucial element for regulated
alternative splicing and for quality control of the resulting
mRNAs. This setting places the large subunit of each native spli-
ceosome, where catalysis by the penta-snRNP presumably
takes place, in the periphery of the supraspliceosome. Thus,
the supraspliceosome presents a platform on which splice junc-
tions could be checked before introns excision. An attractive fea-
ture of such a machine is that it allows rearrangement of splice
junction combinations to select the appropriate ones. This way
it comprises an important tool to ensure the fidelity of splicing
and alternative splicing.
Splicing of a multi-intronic pre-mRNA can be facilitated by the
translocation of the pre-mRNA through the complex in a ‘‘rolling
model’’ fashion. After processing of four introns, the RNA rolls in
to place a new subset of introns in the correct position for their
processing. The possibility that splicing occurs cotranscription-
ally (Neugebauer, 2002) could help explain how pre-mRNAs
having an exceptionally large number of introns (e.g., dystrophin
or CAD) can be spliced by the supraspliceosome in a rolling
mode. At the other extreme, reconstitution experiments with
pre-mRNAs having only one intron indicated that pre-mRNAs
having less then four introns are also packaged in supraspliceo-
somes (Azubel et al., 2006). Thus, the interactions of the RNA
with the native spliceosomes per se are presumably sufficient
to hold the structure together.
Concluding Remarks
Like many biological machines that act on polymeric substrates
(e.g., the ribosome, and the RNA andDNApolymerases) the RNA
splicing machine is expected to be processive. Yet, introns in
multi-intronic transcripts are spliced at different rates and in
a nonsequential mode (Wetterberg et al., 1996), which is charac-
teristic of a distributive process. The proposed mode of action of
the supraspliceosome helps resolve this apparent contradiction
in the sense that it does not require that processing of the four
introns starts and ends simultaneously, while maintaining the
processivity of the machine.
In light of the growing realization that biological processes are
coupled, it is reassuring that the supraspliceosome harbor addi-
tional functional pre-mRNA-processing factors and activities
that have not been reported as components of the in vitro-
assembled spliceosome. These factors are required for addi-
tional processing of pre-mRNA (e.g., the editing enzymes
ADAR1 and ADAR2 [Agranat et al., 2008; Raitskin et al., 2001]).
It also harbors 30-end and 50-end processing components (Rait-
skin et al., 2002). Thus, the supraspliceosome can account for all
aspects of nuclear pre-mRNA-processing activities, including
alternative splicing and quality control of the pre-mRNA.
Clearly, for a better understanding of the intricate network of
interactions among the components of the splicing machine
and how they bring about its function and regulation, it would
be necessary to derive structural information at a higher resolu-Structuretion than that presently available. A major factor that interferes
with deriving such information is that the isolated supraspliceo-
somes represent a steady state population, which is intrinsically
heterogeneous with respect to its pre-mRNA components and
the different stages of the splicing reaction they have reached.
Therefore, it would be necessary to develop methods for the
preparation and isolation of supraspliceosomes assembled on
a single, preselected pre-mRNA at a given stage of the splicing
reaction. Current and future development of methods for the
stabilization of splicing complexes representing intermediate
stages of spliceosomes assembled in vitro should provide
high-resolution information on these complexes, and on specific
interactions between components within them. It is anticipated
that it should be possible to integrate the high-resolution infor-
mation from both the in vitro and in vivo studies in a complemen-
tary and synergistic manner into a coherent mechanistic picture
on pre-RNA splicing and its regulation in the cell nucleus.
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